The doctors and nurses of the more than 400 family offices in the province of Ciego de Ávila will receive the nasalferon, a Cuban biotechnology drug aimed at strengthening the immune system.
The application of the medicine to the health personnel responds to one of the preventive measures to stop the resurgence of COVID-19 in Ciego de Ávila, a province that has been in a phase of limited native transmission for more than 50 days and with 664 positive cases to the disease.
The director of the Provincial Council of Scientific Societies of Health, Silvia Retureta, pointed out that it is the health professionals who have a high risk of catching the SARS Cov-2 coronavirus by staying directly with the patient.
She specified that even when the territory moves to the new normality, the doctors and nurses of the family will be more exposed to contract the virus because the red zone will move towards the community.
Previously the drug was taken by the service personnel, patients, and companions of the two hospitals of the province, those who remained in risk areas, in isolation centers, and the classification consultations in the avilanian health areas.
The Nasalferon, a leading product of Cuban biotechnology, is an immunomodulator, it avoids the replication of the virus and it modifies the number of colonies present in the organism, also, if the sick person does not develop severe symptoms, expressed Retureta.
